Trial intelligence / Profile preview

Continuous Erector Spinae Block Versus Continuous Paravertebral Block Following Thoracotomy

NCT03768440Phase 3Terminated

Sponsor
Boston Children's Hospital
Start
Apr 2019
Primary completion
Feb 2025
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised trial (2 arms), sponsored by Boston Children's Hospital. Primary endpoint: Rescue Analgesic Consumption at 24 hours. Started Apr 2019; status: terminated.

Beyond the preview

Go deeper on NCT03768440.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03768440.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call